Multiple Myeloma/Plasma Cell Neoplasms - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
Studying Chronic Graft-versus-Host Disease
(Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it.
Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.
Improving Allogeneic Stem Cell Transplantation
(Posted: 02/22/2005) - In this study, researchers are testing whether a modified transplantation regimen may reduce complications while preserving the benefits of haploidentical allogeneic stem cell transplantation.
Study of Individuals and Families at High Risk for Blood Cancers
(Posted: 07/27/2004) - Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.
(Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it.
Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.
Improving Allogeneic Stem Cell Transplantation
(Posted: 02/22/2005) - In this study, researchers are testing whether a modified transplantation regimen may reduce complications while preserving the benefits of haploidentical allogeneic stem cell transplantation.
Study of Individuals and Families at High Risk for Blood Cancers
(Posted: 07/27/2004) - Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.
